WO2003014136A1 - 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME - Google Patents

11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME Download PDF

Info

Publication number
WO2003014136A1
WO2003014136A1 PCT/JP2002/008081 JP0208081W WO03014136A1 WO 2003014136 A1 WO2003014136 A1 WO 2003014136A1 JP 0208081 W JP0208081 W JP 0208081W WO 03014136 A1 WO03014136 A1 WO 03014136A1
Authority
WO
WIPO (PCT)
Prior art keywords
represents hydrogen
hydrogen
alkyl
same
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/008081
Other languages
English (en)
French (fr)
Inventor
Toshifumi Asaka
Akira Manaka
Tetsuya Tanikawa
Tomohiro Sugimoto
Youichi Shimazaki
Masakazu Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2003519085A priority Critical patent/JP4311203B2/ja
Publication of WO2003014136A1 publication Critical patent/WO2003014136A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PCT/JP2002/008081 2001-08-08 2002-08-07 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME Ceased WO2003014136A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003519085A JP4311203B2 (ja) 2001-08-08 2002-08-07 １１ａ−アザライド化合物及びその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001240263 2001-08-08
JP2001-240263 2001-08-08

Publications (1)

Publication Number Publication Date
WO2003014136A1 true WO2003014136A1 (en) 2003-02-20

Family

ID=19070904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008081 Ceased WO2003014136A1 (en) 2001-08-08 2002-08-07 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME

Country Status (2)

Country Link
JP (1) JP4311203B2 (ja)
WO (1) WO2003014136A1 (ja)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019238A1 (ja) * 2003-08-22 2005-03-03 Meiji Seika Kaisha, Ltd. 新規アザライド及びアザラクタム誘導体とその製造法
WO2004108744A3 (en) * 2003-05-19 2005-03-24 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
US7015203B2 (en) 1998-01-02 2006-03-21 Pfizer Inc. Macrolides
JP2006528667A (ja) * 2003-05-13 2006-12-21 グラクソ　グループ　リミテッド 新規１４−及び１５−員環化合物
JP2006528947A (ja) * 2003-05-13 2006-12-28 グラクソ　グループ　リミテッド ４”−置換マクロライド
JP2007500193A (ja) * 2003-05-13 2007-01-11 グラクソ　グループ　リミテッド 新規な１４−及び１５−員環化合物
JP2007502313A (ja) * 2003-05-13 2007-02-08 グラクソ　グループ　リミテッド 新規１４及び１５員環化合物
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. １０ａ、１２位架橋型１０ａ－アザライド化合物
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
US8097708B2 (en) 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
WO2017194452A1 (en) * 2016-05-11 2017-11-16 Fidelta D.O.O. Seco macrolide compounds
JP2022507776A (ja) * 2018-11-19 2022-01-18 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用
JP2022507795A (ja) * 2018-11-19 2022-01-18 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０環状置換１３員マクロライド及びそれらの使用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06247996A (ja) * 1993-02-25 1994-09-06 Taisho Pharmaceut Co Ltd ６−ｏ−メチルエリスロマイシンａ誘導体
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06247996A (ja) * 1993-02-25 1994-09-06 Taisho Pharmaceut Co Ltd ６−ｏ−メチルエリスロマイシンａ誘導体
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WADDELL SHERMAN T. ET AL.: "Chimeric azalides with simplified western portions", TETRAHEDRON LETTERS, vol. 34, no. 34, 20 August 1993 (1993-08-20), pages 5385 - 5388, XP002959892 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015203B2 (en) 1998-01-02 2006-03-21 Pfizer Inc. Macrolides
JP2006528667A (ja) * 2003-05-13 2006-12-21 グラクソ　グループ　リミテッド 新規１４−及び１５−員環化合物
JP2006528947A (ja) * 2003-05-13 2006-12-28 グラクソ　グループ　リミテッド ４”−置換マクロライド
JP2007500193A (ja) * 2003-05-13 2007-01-11 グラクソ　グループ　リミテッド 新規な１４−及び１５−員環化合物
JP2007502313A (ja) * 2003-05-13 2007-02-08 グラクソ　グループ　リミテッド 新規１４及び１５員環化合物
WO2004108744A3 (en) * 2003-05-19 2005-03-24 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005019238A1 (ja) * 2003-08-22 2005-03-03 Meiji Seika Kaisha, Ltd. 新規アザライド及びアザラクタム誘導体とその製造法
US7365174B2 (en) 2003-08-22 2008-04-29 Meiji Seika Kaisha, Ltd. Azalide and azalactam derivatives and method for producing the same
JP5015016B2 (ja) * 2006-02-07 2012-08-29 大正製薬株式会社 １０ａ−アザライド化合物
US8097708B2 (en) 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
EP1985620A4 (en) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd 10a-azalide compound
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. １０ａ、１２位架橋型１０ａ－アザライド化合物
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
US10919910B2 (en) 2016-05-11 2021-02-16 Fidelta D.O.O. Seco macrolide compounds
CN109311929A (zh) * 2016-05-11 2019-02-05 菲德尔塔公司 Seco大环内酯化合物
WO2017194452A1 (en) * 2016-05-11 2017-11-16 Fidelta D.O.O. Seco macrolide compounds
CN109311929B (zh) * 2016-05-11 2022-10-04 塞尔维塔公司 Seco大环内酯化合物
US11512096B2 (en) 2016-05-11 2022-11-29 Selvita D.O.O. Seco macrolide compounds
JP2022507776A (ja) * 2018-11-19 2022-01-18 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用
JP2022507795A (ja) * 2018-11-19 2022-01-18 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０環状置換１３員マクロライド及びそれらの使用
JP7551610B2 (ja) 2018-11-19 2024-09-17 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用
JP2025000636A (ja) * 2018-11-19 2025-01-07 ジカニ セラピューティクス， インコーポレイテッド Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用
US12552825B2 (en) 2018-11-19 2026-02-17 Zikani Therapeutics , Inc. C10-alkylene substituted 13-membered macrolides and uses thereof

Also Published As

Publication number Publication date
JP4311203B2 (ja) 2009-08-12
JPWO2003014136A1 (ja) 2004-11-25

Similar Documents

Publication Publication Date Title
WO2003014136A1 (en) 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
AU4022293A (en) 5-0-desosaminylerythronolide a derivative
RU93050129A (ru) Новые производные эритромицина, метод их получения и фармацевтическая композиция на их основе и промежуточные соединения синтеза
CA2105251A1 (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
AU7116691A (en) Process for the preparation of oxetanones
DE69127457D1 (en) 6-0-methylerythromycin a-derivat
WO2002000679A3 (en) 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
CA2349338A1 (en) Novel macrolide antibiotics
AU2466497A (en) Sugar compounds
NO178399C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidino-4-hydroksykromanderivater og analoger derav
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
AU585948B2 (en) Penem compounds, production and use thereof
CA2248953A1 (en) Novel benzofuranone derivatives and process for producing the same
DK0388188T3 (da) Benzoxepinderivater
AU654300B2 (en) 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation
WO2002060878A1 (fr) Derives de benzimidazolidinone
AU636178B2 (en) 7 (alanylaminothiazol-iminoacetamide) substituted cephalosporin derivatives
AU1466601A (en) Improved process for the preparation of trifluoropropanal and its oxime
CA2434408A1 (en) Process for the preparation of heterocyclic indene analogs
AU3067900A (en) Novel derivatives from the class of oleandomycin
CA2335394A1 (en) Aerothricin analogs, their preparation and use
CA2419279A1 (en) Prodrugs to nmda receptor ligands
AU7995800A (en) Antifungal enediynes
WO1987007603A1 (fr) COMPOSES DE beta-LACTAME ET LEUR PROCEDE DE PREPARATION
CA2284501A1 (en) Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2003519085

Country of ref document: JP

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase